Used as a potent antibacterial agent, particularly effective against a broad spectrum of Gram-positive and some Gram-negative bacteria. It functions by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication and transcription, leading to bacterial cell death. Commonly employed in the treatment of respiratory tract infections, skin and soft tissue infections, and urinary tract infections caused by susceptible pathogens. Its stereochemistry enhances target selectivity and improves pharmacokinetic properties, contributing to higher efficacy and reduced resistance development. Often utilized in hospital settings for severe infections and in oral or intravenous formulations depending on infection severity.